Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Metformin × 30 days × Clear all

Phase

Phase 2 5 Phase 1 4 Phase EARLY_PHASE1 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Bevacizumab 3 tremelimumab 2 pembrolizumab 2 olaparib 2 encorafenib 2 X-Rays 2 Specimen Handling 2 Panitumumab 2 Nivolumab 2 Immunotherapy, Adoptive 2 Immunoglobulin G 2 Folfox protocol 2 Disulfides 2 Cyclophosphamide 2 Cetuximab 2 Biopsy 2 ulixertinib 1 tucatinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tocilizumab 1 tipiracil 1 sotorasib 1 senicapoc 1 romiplostim 1 pirtobrutinib 1 perflutren 1 perampanel 1 onvansertib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03905941 2026-02-23

SHK002

University of Virginia

Phase EARLY_PHASE1 Withdrawn

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡